Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 37 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

14 recruiting

Enrollment Performance

Analytics

N/A
14(73.7%)
Phase 2
4(21.1%)
Phase 1
1(5.3%)
19Total
N/A(14)
Phase 2(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials
NCT07507890Not ApplicableRecruiting

Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer

Role: lead

NCT07494201Not ApplicableRecruiting

MIMICC Study in Patients With Colorectal Cancer

Role: lead

NCT07493876Not ApplicableRecruiting

Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With or Without HIPEC

Role: lead

NCT07479095Not ApplicableRecruiting

Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma

Role: lead

NCT03347318Active Not Recruiting

Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease

Role: lead

NCT07479277Not ApplicableRecruiting

Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC

Role: lead

NCT07476547Not ApplicableCompleted

Hypnotic Communication To Reduce Anxiety And Pain During Prostate Biopsy (HYCapp)

Role: lead

NCT07469709Recruiting

A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks

Role: lead

NCT06952101Not ApplicableRecruiting

A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity

Role: lead

NCT06238661Not ApplicableEnrolling By Invitation

Prostate Cancer Screening: a Pilot Study

Role: lead

NCT07453082Recruiting

A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors

Role: lead

NCT07032194Recruiting

Prospective Study on the Use of the Da Vinci SP System in Urological Surgery

Role: lead

NCT06334809Recruiting

INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations

Role: lead

NCT05384002Completed

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Role: lead

NCT06339541Recruiting

The ACC Preclinical Research Platform for Precision Oncology

Role: lead

NCT06324032Recruiting

SUNNYDAY: SUbepithelialgastroiNtestiNal Tumors Detection,accuracYDiAgnosis,ElastographY and Contrast-enhanced EUS

Role: lead

NCT06318559Not ApplicableRecruiting

Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention

Role: lead

NCT02607202Phase 2Completed

A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)

Role: lead

NCT05832736Not ApplicableRecruiting

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer

Role: lead

NCT05821751Not ApplicableUnknown

The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors

Role: lead